Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports July 15 (Reuters) - Eli Lilly LLY.N is in talks to acquire psychedelic drugmaker AtaiBeckley ATAI.O, and a deal could be announced as soon as this week, Bloomberg News reported on Wednesday, citing people familiar with the matter.
Eli Lilly and AtaiBeckley were not immediately available for comment outside regular business hours.
(Reporting by Fabiola Arámburo in Mexico City; Editing by Tasim Zahid)
Recent news on AtaiBeckley
See all newsFDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM